CDC Bioassays

About

About Svar

Career

Distributors

Events

Complement Excellence Award

Products

All Products

Complement Assays

Cell-Based Assays

Gene Therapy Assays

CCP Assays

Services

CRO Services

Diagnostic Services

Custom Cell Development

Cell Manufacturing

Applications

Potency Testing

Safety Assessment

Biomarker Profiling

Clinical Assessment

Bioanalysis

Regulatory Testing

Complement System Evaluation

Gene & Cell Therapy Evaluation

Biosimilar & Biobetter Assessment

Knowledge

Knowledge Hub

Scientific Publications

Videos & Webinars

Product Documentation

iLite CDC Bioassays

Accurate Assessment of Antibody-Mediated Complement-Dependent Cytotoxicity

Accurate Assessment of Antibody-Mediated CDC

iLite CDC Reporter Gene Assays

Our iLite assays streamline the assessment of antibody-mediated CDC, a crucial mechanism in immune responses and a common mechanism of action (MoA) for therapeutic antibodies.

A true measure of cell lysis, ideal for screening mAbs with CDC MoA
Uses the brilliant Svar LUC reporter-gene system for enhanced stability and precise quantification of cell death
"Assay-ready" format for rapid and convenient use
Easily adapted to other targets such as HER2, EGFR, mTNF, mVEGF, or your target of choice

BM5028

iLite^® CD20 (+) Svar Luc Assay Ready Cells

Designed for sensitive and reproducible assessment of CDC activity

CELL-BASED

Your Target of Choice

We can create CDC bioassays for virtually any target.

Didn't find what you were looking for?

We offer products customized to your needs. Our custom iLite^® reporter-gene assays can be adapted to almost any target. We also offer custom ELISA plates and other products. In addition, you can take advantage of our service offerings and let us do the work for you.